Multi-phase hybrid metabolomics framework identifies clinically applicable plasma signatures for early detection of gastric cancer
Summary
A new multi-phase hybrid metabolomics framework has been developed for the early detection of gastric cancer (GC) using plasma samples. This framework integrates untargeted metabolomics with both relative- and absolute-quantitative targeted metabolomics, alongside a custom interpretability-driven algorithm for biomarker identification. Researchers profiled 1,706 plasma samples from multiple cohorts, identifying 84 key metabolites linked to caffeine metabolism and primary bile acid biosynthesis during the relative quantitation phase. Applying the custom algorithm to absolute quantitation data, a 12-metabolite panel was established, covering various functional metabolic modules. Machine learning models utilizing this signature achieved an area under the curve (AUC) of 0.951 in a validation cohort, demonstrating its potential for robust and interpretable translational metabolomics and clinical application.
Key takeaway
For clinical researchers and oncologists focused on early cancer detection, this metabolomics framework offers a promising non-invasive diagnostic tool for gastric cancer. The identified 12-metabolite panel, achieving an AUC of 0.951, provides a robust signature that could significantly improve early diagnosis. You should consider further validation and integration of such multi-modal biomarker panels into routine screening protocols to enhance patient outcomes.
Key insights
A multi-phase metabolomics framework identifies a 12-metabolite panel for early gastric cancer detection with high accuracy.
Principles
- Integrate untargeted and targeted metabolomics.
- Utilize interpretability-driven algorithms for biomarker discovery.
Method
The framework combines untargeted, relative-quantitative, and absolute-quantitative targeted metabolomics with a custom algorithm to identify and validate a multi-metabolite diagnostic panel.
In practice
- Profile plasma samples for non-invasive biomarker discovery.
- Apply machine learning for diagnostic model development.
Topics
- Gastric Cancer Detection
- Plasma Metabolomics
- Multi-phase Hybrid Framework
- Biomarker Discovery
- Machine Learning Diagnostics
Best for: AI Scientist, Research Scientist, Domain Expert
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Machine learning : nature.com subject feeds.